These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3877587)

  • 1. [Effect of corticosteroids on the motor end-plate fine structure in experimental autoimmune myasthenia gravis rats and normal rats].
    Satoh A; Tsujihata M; Takashima H; Hazama R; Nagataki S
    Rinsho Shinkeigaku; 1985 Aug; 25(8):990-1000. PubMed ID: 3877587
    [No Abstract]   [Full Text] [Related]  

  • 2. [The motor end-plate in ocular and generalized myasthenia gravis: a quantitative ultrastructural study (author's transl)].
    Tsujihata M; Hazama R; Takamori M; Shibuya N; Mori K
    Rinsho Shinkeigaku; 1978 Mar; 18(3):149-56. PubMed ID: 668254
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ultrastructural study on the muscle end-plates in a case of myasthenia gravis].
    Tu LH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Oct; 20(5):273-5. PubMed ID: 3450483
    [No Abstract]   [Full Text] [Related]  

  • 4. The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study.
    Engel AG; Tsujihata M; Lindstrom JM; Lennon VA
    Ann N Y Acad Sci; 1976; 274():60-79. PubMed ID: 1066997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural aspects of acetylcholine receptor turnover at the normal end-plate and in autoimmune myasthenia gravis.
    Fumagalli G; Engel AG; Lindstrom J
    J Neuropathol Exp Neurol; 1982 Nov; 41(6):567-79. PubMed ID: 6982313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
    Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
    Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid treatment for experimental autoimmune myasthenia gravis.
    Barone DA; Lambert DH; Poser CM
    Arch Neurol; 1980 Oct; 37(10):663-6. PubMed ID: 7425891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis.
    Ruff RL; Lennon VA
    Ann Neurol; 1998 Mar; 43(3):370-9. PubMed ID: 9506554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphorrhage localized to the muscle end-plate in myasthenia gravis.
    Pascuzzi RM; Campa JF
    Arch Pathol Lab Med; 1988 Sep; 112(9):934-7. PubMed ID: 3415445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations.
    Engel AG; Tsujihata M; Lambert EH; Lindstrom JM; Lennon VA
    J Neuropathol Exp Neurol; 1976; 35(5):569-87. PubMed ID: 956872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental myasthenia: lack of correlation between the autoantibody titer and the reduction of acetylcholine-controlled ionic channels measured at functioning endplates.
    Hohlfeld R; Sterz R; Kalies I; Wekerle H; Peper K
    Muscle Nerve; 1983 Feb; 6(2):160-3. PubMed ID: 6304508
    [No Abstract]   [Full Text] [Related]  

  • 12. Short-term effects of prednisolone on neuromuscular transmission in normal rats and those with experimental autoimmune myasthenia gravis.
    Kim YI; Goldner MM; Sanders DB
    J Neurol Sci; 1979 Apr; 41(2):223-34. PubMed ID: 220391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prednisolone on motor end-plate fine structure: a morphometric study in hamsters.
    Chokroverty S; Reyes MG; Chokroverty M; Kaplan R
    Ann Neurol; 1978 Apr; 3(4):358-65. PubMed ID: 666278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-term administration of ambenonium chloride on motor end-plate fine structure and acetylcholine receptor in rat.
    Hazama R; Tsujihata M; Mori M; Takamori M; Mori K; Shibuya N
    J Neurol Sci; 1981 Jul; 51(1):69-79. PubMed ID: 7252521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of myasthenic immunoglobulin G on the ultrastructure of mouse motor endplate.
    Chen ML; Chiu HC; Tsai MC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1990 May; 23(2):120-5. PubMed ID: 2394186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis.
    Sahashi K; Engel AG; Lambert EH; Howard FM
    J Neuropathol Exp Neurol; 1980 Mar; 39(2):160-72. PubMed ID: 7373347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model.
    Engel AG; Lindstrom JM; Lambert EH; Lennon VA
    Neurology; 1977 Apr; 27(4):307-15. PubMed ID: 557772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental neonatal autoimmune myasthenia gravis: an immunohistochemical, ultrastructural and electrophysiological study of the motor end-plate.
    Tetsuo N; Tsujihata M; Satoh A; Yoshimura T; Nakamura T; Seto M; Nagataki S
    J Neurol Sci; 1995 Oct; 132(2):97-104. PubMed ID: 8543956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of ongoing experimental myasthenia gravis with short term high dose cyclophosphamide.
    Pestronk A; Drachman DB; Adams RN
    Muscle Nerve; 1982 Jan; 5(1):79-84. PubMed ID: 6977088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myasthenia gravis. Prototype of an anti-receptor autoaggression disease (author's transl)].
    Hohlfeld R; Wekerle H
    MMW Munch Med Wochenschr; 1981 Jul; 123(31):1207-11. PubMed ID: 6790965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.